m+Medelevator.RU
← Поиск публикаций
Journal of nanobiotechnology · 2026

Next-generation dynamic and combinatorial nanotherapies for liver cancer: mechanisms, current advances and future perspectives.

СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zhang Baozhu, Iqbal Muhammad Sohaib, Yan Yibin, Wang Han, Wang Xuejin, Zhang Yinghe, Guo Bing

Аннотация

Liver Cancer, one of the most lethal cancers in adults, is distinguished by its aggressive invasion, distinctive tumor microenvironment (TME) and resistance to standard treatments, posing challenges. The TME and fibrotic extracellular matrix (ECM) hampers effective drug distribution; hence, new developments in therapeutics have brought creative solutions to these problems. To temporarily breach these barriers and enable targeted treatment, various dynamic therapies using stimuli such as focused Ultrasound, light, chemical reactions, mechanical stress, microwave induction and magnetic fields have demonstrated great promise in inducing localized and spatiotemporal therapeutic effects. This comprehensive review highlights the therapeutic mechanisms, including both chemical and biological effects and elucidates the therapeutic promise of emerging nanomedicine across individual modalities such as sonodynamic therapy (SDT), photodynamic therapy (PDT) and chemodynamic therapy (CDT), supported by preclinical evidence. Thereafter, promising combinatorial dynamic strategies with superior therapeutic effects are outlined. Furthermore, emerging next-generation modalities, including piezodynamic therapy (PZDT), microwave dynamic therapy (MWDT) and magnetodynamic therapy (MDT), with their therapeutic perspectives are discussed in detail. Although these strategies employing emerging nanomedicines have shown remarkable therapeutic potential for clinical translation, controlling physical stimulation and ensuring nanoparticle biocompatibility remain challenging. Continued innovations in medicine and chemistry will be essential for transforming dynamic strategies into clinically viable strategies for liver oncology.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты